ROCKWELL MEDICAL, INC.
corporate_fare Company Profile
ROCKWELL MEDICAL, INC. (NASDAQ:RMTI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 20 items for RMTI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-13, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for RMTI spans 8-K, 10-Q, DEF 14A, PRE 14A.
Recent high-impact activity:
- Rockwell Medical Sets 2029 Targets: $100M+ Sales, 30% Gross Margin, No New Fundraising Needed
- Rockwell Medical Q2 2026: Sales Up 11%, Gross Margin Expands to 18%, Cash Flow Positive
- Rockwell Medical Q2 Sales Rise 11%, Gross Margin Expands to 18%; Reiterates 2026 Guidance
- Rockwell Medical Q2 Sales Rise 11% on New Customers, Guides to $70-75M Revenue
- Rockwell Medical Regains Nasdaq Compliance After Reverse Split
Financial Snapshot
Short Interest & Short Volume
4.59 days to coverFINRA reported short interest of 89,869 shares in RMTI as of the September 15, 2026 settlement, a 3.3% decrease from the prior period — about 4.6 days to cover at its recent average daily volume. On October 2, 2026, 62.8% of RMTI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.